| US6025355A (en) | 1997-05-19 | 2000-02-15 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
| JP2002536411A (en) | 1999-02-09 | 2002-10-29 | ブリストル−マイヤーズ スクイブ カンパニー | Lactam inhibitors of factor Xa and methods |
| SI1268418T1 (en)* | 2000-03-27 | 2006-10-31 | Applied Research Systems | Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| SK13832002A3 (en)* | 2000-03-27 | 2003-03-04 | Applied Research Systems Ars Holding N. V. | Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| GB0010757D0 (en) | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
| US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
| CA2434184A1 (en)* | 2001-01-19 | 2002-09-12 | Pharmacopeia, Inc. | Bisaryl derivatives having fsh receptor modulatory activity |
| US6900213B2 (en) | 2001-01-19 | 2005-05-31 | Pharmacopeia Drug Discovery, Inc. | Bisaryl derivatives having FSH modulatory activity |
| HRP20030669A2 (en) | 2001-02-23 | 2005-06-30 | Merck & Co. Inc. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| JP2005511478A (en) | 2001-04-03 | 2005-04-28 | メルク エンド カムパニー インコーポレーテッド | N-substituted non-aryl heterocyclic amidyl NMDA / NR2B antagonist |
| DE60224521T2 (en)* | 2001-05-05 | 2009-01-08 | Smithkline Beecham P.L.C., Brentford | Cyclic N-aroylamines |
| GB0115862D0 (en)* | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
| CZ20042A3 (en)* | 2001-07-02 | 2004-04-14 | Akzo Nobel N. V. | Tetrahydroquinoline derivatives |
| GB0121941D0 (en) | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| HRP20040278B1 (en)* | 2001-10-22 | 2008-03-31 | Laboratoires Serono Sa | GONADOTROPINS FOR FOLICULOGENESIS |
| CA2499732A1 (en) | 2002-09-20 | 2004-04-15 | Applied Research Systems Ars Holding N.V. | Piperazine derivatives and methods of use |
| TWI306855B (en)* | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
| CN100404508C (en)* | 2002-12-20 | 2008-07-23 | 欧加农股份有限公司 | Tetrahydroquinoline derivatives |
| CN100386318C (en)* | 2002-12-20 | 2008-05-07 | 欧加农股份有限公司 | Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| TWI322012B (en)* | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
| UA88879C2 (en)* | 2003-09-02 | 2009-12-10 | Эплайд Рисерч Системз Эрс Холдинг Н.В. | Fsh glycosylation mutant |
| JP2008504012A (en)* | 2004-01-28 | 2008-02-14 | シントニックス・ファーマシューティカルズ・インコーポレーテッド | Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion protein for infertility treatment |
| US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| JPWO2006095922A1 (en)* | 2005-03-10 | 2008-08-21 | 京都薬品工業株式会社 | Tetrahydroisoquinoline compound and pharmaceutical use thereof |
| UA92008C2 (en) | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| PL1879866T3 (en) | 2005-05-04 | 2011-07-29 | N V Organon | Dihydropyridine derivatives |
| UA92009C2 (en) | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QЛIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| UA92007C2 (en) | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| JP2008540567A (en) | 2005-05-12 | 2008-11-20 | ワイス | Pyrrolobenzodiazepine and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists |
| AU2006258007A1 (en) | 2005-06-09 | 2006-12-21 | Wyeth | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| US20090018142A9 (en)* | 2006-05-02 | 2009-01-15 | Zhengping Zhuang | Use of phosphatases to treat tumors overexpressing N-CoR |
| CA2652061A1 (en)* | 2006-05-17 | 2007-11-29 | Marvin C. Gershengorn | Pyrimidine low molecular weight ligands for modulating hormone receptors |
| WO2008014199A2 (en) | 2006-07-28 | 2008-01-31 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the cb2 receptor |
| CN103788108B (en) | 2007-02-06 | 2017-04-12 | 利克斯特生物技术公司 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| US8143445B2 (en)* | 2007-10-01 | 2012-03-27 | Lixte Biotechnology, Inc. | HDAC inhibitors |
| WO2009061652A1 (en) | 2007-11-07 | 2009-05-14 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| TW200944523A (en)* | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
| EP2326629B1 (en) | 2008-07-10 | 2013-10-02 | Boehringer Ingelheim International GmbH | Sulfone compounds which modulate the cb2 receptor |
| US8227473B2 (en) | 2008-08-01 | 2012-07-24 | Lixte Biotechnology, Inc. | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| CA2730148C (en) | 2008-08-01 | 2018-04-03 | Lixte Biotechnology, Inc. | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| WO2010147612A1 (en) | 2009-06-18 | 2010-12-23 | Lixte Biotechnology, Inc. | Methods of modulating cell regulation by inhibiting p53 |
| KR20110063485A (en) | 2008-09-25 | 2011-06-10 | 베링거 인겔하임 인터내셔날 게엠베하 | Sulfonyl Compounds Selectively Modulate CB2 Receptors |
| CA2749163A1 (en)* | 2009-01-14 | 2010-07-22 | The Salk Institute For Biological Studies | Methods for screening and compounds that protect against amyloid diseases |
| WO2010096371A2 (en) | 2009-02-18 | 2010-08-26 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds which modulate the cb2 receptor |
| US8071587B2 (en) | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
| TWI461426B (en)* | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | (dihydro)imidazoiso[5,1-a]quinolines |
| US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| EP2443107B1 (en)* | 2009-06-16 | 2018-08-08 | Boehringer Ingelheim International GmbH | Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor |
| US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| TW201116531A (en) | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
| TW201116515A (en) | 2009-07-31 | 2011-05-16 | Organon Nv | Dihydrobenzoindazoles |
| USRE46608E1 (en) | 2009-09-01 | 2017-11-14 | Catabasis Pharmaceuticals, Inc. | Fatty acid niacin conjugates and their uses |
| SG10201500431SA (en) | 2009-09-01 | 2015-03-30 | Catabasis Pharmaceuticals Inc | Fatty acid niacin conjugates and their uses |
| WO2011037795A1 (en) | 2009-09-22 | 2011-03-31 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the cb2 receptor |
| JP2013517271A (en) | 2010-01-15 | 2013-05-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Compounds that modulate the CB2 receptor |
| EP2542539B1 (en) | 2010-03-05 | 2014-02-26 | Boehringer Ingelheim International GmbH | Tetrazole compounds which selectively modulate the cb2 receptor |
| WO2012012307A1 (en) | 2010-07-22 | 2012-01-26 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the cb2 rece |
| CA2837524C (en) | 2011-07-01 | 2019-08-20 | Merck Patent Gmbh | Dihydropyrazoles |
| EP3263568B1 (en) | 2011-07-18 | 2021-08-25 | Merck Patent GmbH | Benzamides |
| CN104080784B (en) | 2012-01-10 | 2017-07-18 | 默克专利有限公司 | Heterocyclic carbamate derivatives as follicular stimulating hormone conditioning agent |
| EP2812320B1 (en) | 2012-02-08 | 2018-03-07 | Merck Patent GmbH | Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor |
| CN105209036B (en) | 2013-04-09 | 2018-10-26 | 莱克斯特生物技术公司 | The preparation of oxa-bicyclo heptane and oxabicyclo heptene |
| EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
| ES2657979T3 (en) | 2013-06-24 | 2018-03-07 | Merck Patent Gmbh | Imidazole compounds as modulators of FSHR and their uses |
| RU2663898C2 (en) | 2013-06-24 | 2018-08-13 | Мерк Патент Гмбх | Pyrazole compounds as modulators of fshr and uses thereof |
| US11433047B2 (en) | 2015-10-09 | 2022-09-06 | Neurotheryx Canada Ltd. | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases |
| BR112019011627A2 (en) | 2016-12-08 | 2019-11-12 | Lixte Biotechnology Inc | oxabicycloheptanes for immune response modulation |
| US10729689B2 (en)* | 2017-10-26 | 2020-08-04 | University Of Puerto Rico | Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents |
| JP7558267B2 (en) | 2019-10-25 | 2024-09-30 | ギリアード サイエンシーズ， インコーポレイテッド | GLP-1R modulating compounds |
| CN120518596A (en) | 2020-01-29 | 2025-08-22 | 吉利德科学公司 | GLP-1R modulating compounds |
| WO2022109182A1 (en) | 2020-11-20 | 2022-05-27 | Gilead Sciences, Inc. | Polyheterocyclic glp-1 r modulating compounds |
| EP4304711A1 (en) | 2021-03-11 | 2024-01-17 | Gilead Sciences, Inc. | Glp-1r modulating compounds |
| US12180197B2 (en) | 2021-03-11 | 2024-12-31 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| US11858918B2 (en) | 2021-04-21 | 2024-01-02 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| TW202435866A (en) | 2023-03-08 | 2024-09-16 | 荷蘭商菲林公司 | Small molecule fsh receptor modulators |
| CN117510475A (en)* | 2023-11-01 | 2024-02-06 | 江苏缘龙医院管理有限责任公司 | Musashi protein inhibitors that interfere with RNA-protein interactions and their applications |